Sartorius Stedim Biotech has signed a global partnership agreement that covers arrangements concerning the mutual development of innovative fluid systems and marketing of single-use tubing.
Raumedic will produce and supply the systems to Sartorius Stedim Biotech on a long-term basis.
Sartorius Stedim Biotech will be combining its designing, manufacturing and validation expertise in single-use systems for biopharmaceutical applications with Raumedic proficiency in the development and manufacture of tubing for medical and biopharmaceutical use.
The alliance will provide reliable fluid-handling systems to biopharmaceutical manufacturers.
Through this strategic partnership with Raumedic, Sartorius Stedim Biotech will substantially expand its product and service portfolio in the area of liquid-transfer technologies.
The companies will merge their expertise for generating new tubing technologies and validation standards.
With a new product line, Tuflux, which will soon be launched, Sartorius Stedim Biotech will supply its customers with highly validated polymer and silicone tubing on single-use assemblies, as well as standalone tubing coils and comprehensive validation packages.
According to the agreement, Sartorius Stedim Biotech will offer its products backed by Raumedic's support and assistance in order to develop customised solutions and to provide stronger validation and technical support, as well as process improvements.